Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07618754

Shame, Resilience and Well-being After Intimate Partner Violence: an Intervention Study With Replicated Single-Subject Design.

The EMBER protocol is a health care method that is designed to increase resilience, in order to improve well-being and overall health in women who have experienced violence by a partner. This study explores whether the EMBER intervention works in this way. Eight participants will take part in the EMBER program and complete questionnaires every week during the intervention. The researchers will compare the timeline for the intervention to how resilience levels change. They will also check whether changes in resilience are linked to changes in health and well-being.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Intimate Partner Violence Resilience, Psychological Wounds and Injuries

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Intimate partner violence (IPV) is a global problem with complex consequences in society as well as for the victim/survivor. The EMBER-protocol was developed at National Center for Knowledge on Men´s violence against Women, Uppsala University, Sweden. The purpose of the protocol is to provide women who have been subjected to IPV with support and tools for empowerment and improving resilience, thereby improving health and well-being. In this study with replicated single-case design, 8 patients will complete questionnaires bi-weekly while taking part of the intervention, starting from their very first contact with the clinic. The questionnaires are completed using a mobile application. Data will be processed using a combination of visual and statistical analysis, in order to examine how interventions intended to improve resilience, changes in resilience measures and changes in well-being and health relate to each other temporally.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • subjected to IPV within 2 years prior to enrollment
  • capable of completing questionnaires using a mobile phone
  • intention to complete intervention
  • identifies as female

Exclusion criteria

  • ongoing severe IPV
  • ongoing severe substance use
  • psychosis
  • moderate to severe suicidality
  • ongoing psychological intervention in other facility

Treatment and study plan

Resilience enhancing intervention, individual format

Other

A 4-step, Resilience-focused intervention based on the Resilience Portfolio Model, administered in individual format.

Other names: EMBER Phase A

Resilience enhancing intervention, group format

Other

A 4-step, Resilience-focused intervention based on the Resilience Portfolio Model, administered in group format.

Other names: EMBER phase C

Primary outcomes

  1. Resilience - Psychological Endurance

    Time frame: Bi-weekly from enrollment 2-6 weeks prior to start of intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.

    The self assessment questionnaire Psychological Endurance Scale (range 6-24, higher value indicates higher endurance) is completed bi-weekly using a mobile application. Data will be analyzed with a combination of visual and statistical analyses.

  2. Resilience - Subjective Social Support

    Time frame: Bi-weekly from enrollment 2-6 weeks prior to start of intervention to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.

    The Oslo Subjective Social Support Scale - 3 items (range 3-14, higher value indicates higher level of social support) is completed bi-weekly using a mobile application. Data will be processed using a combination of visual and statistical analyses.

  3. Resilience - Meaning Making

    Time frame: Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.

    The MAPS - Meaningfulness subscale (range 5-25, higher value indicating higher meaningfulness) is completed by the subjects bi-weekly. Data is processed using a combination of statistical and visual analyses.

Secondary outcomes

  1. Health

    Time frame: Bi-weekly from enrollment 2-6 weeks prior to the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 weeks post-intervention.

    General, Somatic, Mental, Social and Sexual health is measured by 5 questions regarding subjective health the past week which are administered to the subject using a mobile application. The subject grades ones health on a visuoanalogue scale ranging from -10 to +10. The range on the total scale is thus -50 to +50, subscales -10 to +10. Higher value indicates better health. Data is processed using a combination in visual and statistical analyses.

  2. Shame

    Time frame: Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up 6 at weeks post-intervention.

    Shame is measured using the External and Internal Shame Scale (EISS; range 0.00-4.00, higher value indicating higher levels of shame), administered to patients using a mobile application. Data is processed using a combination of statistical and visual analyses.

  3. Well-Being

    Time frame: Bi-weekly from enrollment 2-6 weeks prior to start of the intervention, to completion of the intervention (intervention phase A and/or C). Follow-up at 6 weeks post-intervention.

    Well-being is measured bi-weekly using the Questionnaire on Well-Being (QWB, range 0-72, higher value indicating more wellbeing). Data is processed using a combination of statistical and visual analyses.

Study contacts

Contact information is provided by the study sponsor or research team.

Tove Filén, PhD-student

CONTACT

[email protected]

+46186170785

Sponsors and collaborators

Lead sponsor

Uppsala University

Other

Registry information

Acronym: EMBER-4

Important dates

Study start
2026
Primary completion
2030
Study completion
2030
First posted
Jun 1, 2026
Registry last updated
Jun 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.